Pt Kalbe Farma Stock Total Debt
PTKFF Stock | USD 0.09 0 2.89% |
PT Kalbe Farma fundamentals help investors to digest information that contributes to PT Kalbe's financial success or failures. It also enables traders to predict the movement of PTKFF Pink Sheet. The fundamental analysis module provides a way to measure PT Kalbe's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PT Kalbe pink sheet.
PTKFF |
PT Kalbe Farma Company Total Debt Analysis
PT Kalbe's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current PT Kalbe Total Debt | 490.28 B |
Most of PT Kalbe's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PT Kalbe Farma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition |
Based on the latest financial disclosure, PT Kalbe Farma has a Total Debt of 490.28 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The total debt for all United States stocks is significantly lower than that of the firm.
PTKFF Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PT Kalbe's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PT Kalbe could also be used in its relative valuation, which is a method of valuing PT Kalbe by comparing valuation metrics of similar companies.PT Kalbe is currently under evaluation in total debt category among related companies.
PTKFF Fundamentals
Return On Equity | 0.17 | |||
Return On Asset | 0.11 | |||
Profit Margin | 0.12 % | |||
Current Valuation | 6.11 B | |||
Shares Outstanding | 46.26 B | |||
Shares Owned By Insiders | 58.08 % | |||
Shares Owned By Institutions | 15.23 % | |||
Price To Book | 5.15 X | |||
Price To Sales | 3.56 X | |||
Revenue | 26.26 T | |||
Gross Profit | 11.11 T | |||
EBITDA | 4.54 T | |||
Net Income | 3.18 T | |||
Cash And Equivalents | 189.29 M | |||
Total Debt | 490.28 B | |||
Debt To Equity | 0.03 % | |||
Current Ratio | 4.08 X | |||
Book Value Per Share | 0.02 X | |||
Cash Flow From Operations | 2.83 T | |||
Number Of Employees | 12.64 K | |||
Beta | 0.32 | |||
Market Capitalization | 7.34 B | |||
Total Asset | 25.67 T | |||
Retained Earnings | 10.82 T | |||
Working Capital | 6.76 T | |||
Current Asset | 9.22 T | |||
Current Liabilities | 2.46 T | |||
Z Score | 1.0 | |||
Annual Yield | 0.02 % | |||
Net Asset | 25.67 T |
About PT Kalbe Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PT Kalbe Farma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PT Kalbe using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PT Kalbe Farma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PT Kalbe Farma using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PT Kalbe Farma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the PT Kalbe Farma information on this page should be used as a complementary analysis to other PT Kalbe's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for PTKFF Pink Sheet analysis
When running PT Kalbe's price analysis, check to measure PT Kalbe's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PT Kalbe is operating at the current time. Most of PT Kalbe's value examination focuses on studying past and present price action to predict the probability of PT Kalbe's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PT Kalbe's price. Additionally, you may evaluate how the addition of PT Kalbe to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |